SAGENT PHARMACEUTICALS INC COM STK (DE)
SGNT
SGNT was delisted on the 29th of August, 2016.
128 hedge funds and large institutions have $486M invested in SAGENT PHARMACEUTICALS INC COM STK (DE) in 2016 Q2 according to their latest regulatory filings, with 14 funds opening new positions, 52 increasing their positions, 39 reducing their positions, and 21 closing their positions.
10,380% more call options, than puts
Call options by funds: $524K | Put options by funds: $5K
50% more funds holding in top 10
Funds holding in top 10: 2 → 3 (+1)
33% more repeat investments, than reductions
Existing positions increased: 52 | Existing positions reduced: 39
23% more capital invested
Capital invested by funds: $395M → $486M (+$90.3M)
6% less funds holding
Funds holding: 136 → 128 (-8)
33% less first-time investments, than exits
New positions opened: 14 | Existing positions closed: 21
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NIMC
NWQ Investment Management Company
Los Angeles,
California
|
+$16M |
| 2 |
Ameriprise
Minneapolis,
Minnesota
|
+$4.12M |
| 3 |
TA
Tamarack Advisers
Carlsbad,
California
|
+$3.33M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$2.93M |
| 5 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
+$2.88M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EAM
EverPoint Asset Management
Stamford,
Connecticut
|
-$11M |
| 2 |
Balyasny Asset Management
Chicago,
Illinois
|
-$8.33M |
| 3 |
SAM
Sectoral Asset Management
Montreal,
Quebec, Canada
|
-$6.33M |
| 4 |
Millennium Management
New York
|
-$3.98M |
| 5 |
Franklin Resources
San Mateo,
California
|
-$1.69M |
SGNT Hedge Fund Activity: Q2 2016 in Review
128 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in SAGENT PHARMACEUTICALS INC COM STK (DE) (SGNT) for Q2 2016, worth a combined $486M — up 23% from $395M a quarter earlier.
Sellers outnumbered buyers: 21 funds closed out of SGNT and 14 opened new positions — a net loss of 7 holders — while 39 trimmed existing stakes and 52 added.
The largest buyer was NWQ Investment Management Company, opening a new position worth an estimated $16M. The largest seller was EverPoint Asset Management, exiting entirely with an estimated $11M sold.
- 128 institutional investors held SAGENT PHARMACEUTICALS INC COM STK (DE) (SGNT) as of Q2 2016, down from 136 in Q1 2016.
- Funds reported $486M of SAGENT PHARMACEUTICALS INC COM STK (DE) stock for Q2 2016, up 23% quarter-over-quarter.
- 14 funds opened new SAGENT PHARMACEUTICALS INC COM STK (DE) positions in Q2 2016 and 21 closed out, a net change of -7 holders.
- The largest SAGENT PHARMACEUTICALS INC COM STK (DE) buyer in Q2 2016 was NWQ Investment Management Company, an estimated $16M added.
- The largest SAGENT PHARMACEUTICALS INC COM STK (DE) seller in Q2 2016 was EverPoint Asset Management, an estimated $11M sold.
Based on aggregated 13F filings for Q2 2016.